Perspective
Factor VIII manufactured from plasma—the ups and downs, and the up again: a personal journey—part 2: aspects of factor VIII manufacture from plasma
Annals of Blood
2018;
3:
20
(28 February 2018)
Perspective
Recent market status and trends of fractionated plasma products
Annals of Blood
2018;
3:
19
(28 February 2018)
Editorial
Cardiovascular genetics: a super-bright or over-hyped perspective?
Annals of Blood
2018;
3:
18
(28 February 2018)
Perspective
Factor VIII manufactured from plasma—the ups and downs, and the up again: a personal journey—part 1: history of the development of plasma-derived factor VIII therapies
Annals of Blood
2018;
3:
17
(28 February 2018)
Viewpoint
Labeling tubes before collection threatens patient safety
Annals of Blood
2018;
3:
16
(26 February 2018)
Perspective
Plasma fractionation in China: progress and challenges
Annals of Blood
2018;
3:
15
(26 February 2018)
Review Article
Building blocks of the viral safety margins of industrial plasma products
Annals of Blood
2018;
3:
14
(26 February 2018)
Meet the Professor
Profs. Erica Wood and Masahiro Satake—sharing, learning and improving
Annals of Blood
2018;
3:
13
(05 February 2018)
Meet the Professor
Prof. Steve Henry: Kode technology—a magic biological paint
Annals of Blood
2018;
3:
12
(02 February 2018)
Meet the Professor
Interview with Prof. Roger Y. Dodd and Prof. Susan L. Stramer: pathogen inactivation, a technology that will help reduce the emerging infections
Annals of Blood
2018;
3:
11
(02 February 2018)
Meet the Professor
Interview with Prof. Martin L. Olsson—meeting the challenge of blood group genotyping to provide safe blood for transfusion
Annals of Blood
2018;
3:
10
(02 February 2018)
Original Article
Diagnosis and management of von Willebrand disease in Slovakia
Annals of Blood
2018;
3:
9
(01 February 2018)
Meet the Professor
Interview with Prof. Evan Martin Bloch—public and clinical awareness of babesiosis is critical
Annals of Blood
2018;
3:
8
(01 February 2018)